Ankylosing Spondylitis and the Spondyloarthropathies: A Companion to Rheumatology 3E: 9780323031042: Medicine & Health Science Books @ Amazon.com
Assessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis - van der Heijde - 2005 - Arthritis & Rheumatism - Wiley Online Library
Désirée van der Heijde, MD, PhD: Safety, Efficacy of Bimekizumab in Ankylosing Spondyloarthritis
Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances - The Rheumatologist
Secukinumab may slow structural ankylosing spondylitis progression | MDedge Rheumatology
Nieuwe voorzitter van de Ruggesteun bekend – Meer/Vandaag
PDF) Effects of baricitinib on radiographic progression of structural joint damage at 1 year in patients with rheumatoid arthritis and an inadequate response to conventional synthetic Disease-Modifying antirheumatic drugs
Researcher comment: The SELECT-AXIS 1 trial | Désirée van der Heijde - YouTube
Dies Natalisviering 2012, met uitreiking van eredoctoraten-10320 | Beeldbank
Panel revises spondyloarthritis treat-to-target recommendations | MDedge Rheumatology
Désirée van der Heijde - Leiden University
Instrument development. ASDAS score with Desirée Van der Heijde - YouTube
Upadacitinib improves signs, symptoms in patients with active AS
EULAR 2020 - Speaker interview: 48 week data of Bimekizumab in r-axSpA - YouTube
Prof.dr. D.M.F.M. (Désirée) van der Heijde (https://www.narcis.nl)
Désirée van der Heijde - Leiden University
Top rheumatology research showcased at Plenary III session - ACR Convergence Today
Désirée van der Heijde: H-index & Awards - Academic Profile | Research.com
Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances - Page 3 of 6 - The Rheumatologist
Nieuwe voorzitter van de Ruggesteun bekend | Désirée van der Heijde is de nieuwe voorzitter van de Ruggesteun. Zij volgt Ludy Nijsten op die in juli overleed. In aanloop naar de inzamelingsactie...
Sarilumab showed sustained effect on RA progression at 3 years | MDedge Rheumatology
Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances - Page 4 of 6 - The Rheumatologist
Uncertainty common for those treating patients with non-radiographic axial spondyloarthritis - ACR Convergence Today
Psoriatic Arthritis Workshop OMERACT May 14 th, 2004 Steering Committee Dafna Gladman, Philip Mease, Gerald Krueger, Désirée van der Heijde, Christian. - ppt download
